Literature DB >> 31061546

THE CHALLENGE OF ACHIEVING ADEQUATE ORAL IMMUNOSUPPRESSION IN A RENAL TRANSPLANT RECIPIENT WHO DEVELOPS SHORT BOWEL SYNDROME (SBS).

O M McCloskey, A Woodman, A Mitchell, J Smyth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 31061546      PMCID： PMC6500423     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  5 in total

1.  Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel.

Authors:  M Novelli; P Muiesan; G Mieli-Vergani; A Dhawan; M Rela; N D Heaton
Journal:  Transpl Int       Date:  1999       Impact factor: 3.782

2.  Oral administration of tacrolimus in the presence of jejunostomy after liver transplantation.

Authors:  T Hasegawa; K Nara; T Kimura; H Soh; T Sasaki; T Azuma; A Okada
Journal:  Pediatr Transplant       Date:  2001-06

3.  The colon displays an absorptive capacity of tacrolimus.

Authors:  K Nishi; T Ishii; M Wada; S Amae; N Sano; M Nio; Y Hayashi
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

4.  Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.

Authors:  Christin C Rogers; Rita R Alloway; J Wesley Alexander; Michael Cardi; Jennifer Trofe; Alexander A Vinks
Journal:  Clin Transplant       Date:  2008 May-Jun       Impact factor: 2.863

5.  The use of oral tacrolimus in a case of short bowel syndrome.

Authors:  Nilay Patel; Stuart Smith; Ashok Handa; Chris Darby
Journal:  Transpl Int       Date:  2003-09-03       Impact factor: 3.782
  5 in total
  1 in total

1.  Changes of Drug Pharmacokinetics in Patients with Short Bowel Syndrome: A Systematic Review.

Authors:  Wallace Bok-Thoe Hong; Wee Kiat Tan; Lawrence Siu-Chun Law; David Eng-Hui Ong; Elaine Ah-Gi Lo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-07-01       Impact factor: 2.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.